Sodium alginate as a novel therapeutic option in experimental colitis.
about
Alginate-Derived Oligosaccharide Inhibits Neuroinflammation and Promotes Microglial Phagocytosis of β-Amyloid.A Comparative Study upon the Therapeutic Indices of Some Natural and Synthetic Anti-inflammatory Agents.Phytochemicals and their potential usefulness in inflammatory bowel disease.Preventative Effects of Sodium Alginate on Indomethacin-induced Small-intestinal Injury in Mice.Sodium alginate ameliorates indomethacin-induced gastrointestinal mucosal injury via inhibiting translocation in rats.
P2860
Sodium alginate as a novel therapeutic option in experimental colitis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Sodium alginate as a novel therapeutic option in experimental colitis.
@en
type
label
Sodium alginate as a novel therapeutic option in experimental colitis.
@en
prefLabel
Sodium alginate as a novel therapeutic option in experimental colitis.
@en
P2860
P50
P1476
Sodium alginate as a novel therapeutic option in experimental colitis
@en
P2093
P2860
P304
P356
10.1111/J.1365-3083.2005.01571.X
P577
2005-04-01T00:00:00Z